Article

Aloka Vision Programme: Social business, not charity

#Loveyoureyes - World Sight Day 2023

8 October 2023
Aloka Vision Programme: Social business, not charity

Article first published: October 2023

The core idea of Aloka as a social business, to create a self-sustaining and self-growing project, is working after several changes in the supply chain and business model, with ZEISS in the role of driving program development, developing new technologies and onboarding new partners. Every month, 60-80,000 patients are served through Aloka, with some interruptions due to the monsoon season or festivals.

Why sell glasses and not give them away? Serving patients as clients and not as beneficiaries includes their right to quality, proper counseling and available services in their community. The barriers to eye care in rural areas are the lack of eye care professionals for eye exams and vision testing, and the high cost of getting eyeglasses, including the loss of a day's wages, travel costs, and buying eyeglasses at the nearest optical shop. With Aloka, we bring optometrists and ophthalmologists to the villages and provide glasses and service at a fraction of the cost of eye care at the nearest available optical shop. This makes eye and vision care available, affordable and accessible to underserved communities. Proceeds are used to expand the program and generate income for local NGOs and health workers who continue to support the program with essential work: raising awareness of clear and healthy vision, mobilizing communities, and building trust in Aloka's services.

  • Aloka Vision Programme: Social business, not charity

    Every month, 60-80,000 patients are served through Aloka, with some interruptions due to the monsoon season or festivals.

  • Eye exam in the Aloka Vision Programme.

    With Aloka, we bring optometrists and ophthalmologists to the villages and provide glasses and service at a fraction of the cost of eye care at the nearest available optical shop.

  • Aloka Vision Programme: Social business, not charity

    Aloka makes eye and vision care available, affordable and accessible to underserved communities.

Results of customer calls 4-6 weeks after purchase show that more than 95% are very satisfied or satisfied with Aloka's services, products and pricing, and compliance with spectacle use averages 78%. In 2022/23, we conducted telephone interviews with 21,226 Aloka customers, learning important things about local needs, customer satisfaction and desired activities for further program development.

Another expression of respect for patients is quality: adherence to eye exam and vision testing standards, staff qualifications and product quality. Any compromise in quality is followed by lower acceptance and compliance with spectacle wear or referral for medical treatment. In addition to the likely disappointment of patients, the consequences of poor quality should affect the efficiency, effectiveness, and impact of the entire program.

Research shows that a significant portion of a program's effort is spent on awareness, mobilization, infrastructure, and logistics in underserved areas. Joining forces with organizations and teams that are strong in these areas, with the eye care and vision care capabilities of a company like ZEISS and the expert team of Aloka, multiplies the impact for the simple reason that everyone bringing their best to the table dramatically increases efficiency and reduces costs. The more we can do with the available resources of team power, time, supply chain and money. Partnerships are key. As is the sharing of practices and experiences to avoid mistakes and make the most of lessons learned and the different expertise of partners.

And, sustainability matters. Clear, healthy vision must last a lifetime. So should eye care. Therefore, each program should provide frequent and reliable service in the selected region. One-time activities are disappointing to people, not beneficial to public health, and usually a waste of time, money, and acceptance.

About the Aloka Vision Programme

Aloka has been operational in India since 2015. The team is based in Bengaluru, Karnataka for all field operations, partner relations, supply chain and program development. Today it is led by Dr. Premjeeth Moodbidri with a core team of optometrists and back-office staff. It is supported by the Optometry Council of India, students from optometry colleges, Lions Club volunteers, ophthalmologists, health workers - and our partners: non-governmental organizations committed to promoting clear vision for all.

The entire operation is set up as an independent entity, initiated and supported by ZEISS, but self-governed and working as a partnership network for NGOs, hospitals, and institutions. The Aloka Vision Program is part of ZEISS' social engagement and social business strategy and has been established to contribute to the sustainability goals of the ZEISS Group, which include a commitment to eye care and public health.

About ZEISS

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 8.8 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2022).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership. ZEISS invests 13 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With over 38,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2022). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com

 

ZEISS Vision Care
ZEISS Vision Care is one of the world's leading manufacturers of eyeglass lenses and ophthalmic instruments. The unit is allocated to the Consumer Markets segment and develops and produces offerings for the entire eyeglass value chain that are distributed globally under the ZEISS brand.

Portrait Joachim Kuss
Press contact Joachim Kuss General Topics and Sustainability

ZEISS Vision Care


Share this page